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1. Introduction 
The development of massively parallel DNA sequencing is revealing the scale of 
mammalian bacterial colonization and suggests that Homo sapiens is colonized by between 
103 and 104 bacterial phylotypes. The understanding of the complexity of host-bacterial 
interactions could explain why only a relatively tiny number of bacteria causing human 
diseases (Keijser et al., 2008; McKenna et al., 2008; Henderson et al., 2011). Over thousands 
of years microbes and mammals have co-evolve resulting in extraordinarily sophisticated 
molecular mechanism permitting the organism to survive together. Mycobacterium 
tuberculosis is one of the best examples of successful coevolution, since the bacilli have 
infected one third of the human population, but in 90% of the cases without causing overt 
disease (Bhowruth et al., 2008). The factors that regulate the course and outcome of 
infection by M. tuberculosis are multifaceted and involve a complex interplay between the 
immune system of the host and survival strategies employed by the bacilli (Mischenko et 
al., 2004). During the infection process and pathological development of human 
tuberculosis, M. tuberculosis expresses many molecules and recruits others from the host 
that allow the microorganism to recognize and be recognized by different host receptors. 
In this way, the knowledge of these interactions at the molecular level is of fundamental 
importance to understand all the events involved in entry, dissemination and persistence 
of the pathogenic mycobacteria and in the design of new highly specific therapeutic 
agents. 
In this chapter, we are describing the host and the human pathogen M. tuberculosis 
molecules that are involved in the interactions with innate immune system, Extracellular 
Matrix Protein (ECM) and fibrinolytic system, the proposal mechanisms of interactions and 
the biological/pathological consequences are discussed. Also, examples are shown of how 
genetic variations in host and bacteria regulatory and encoded sequences can affect 
conditions that influence the relationship between bacteria and their host. Finally 
considerations are done about how the knowledge of host-pathogen interactions, can be 
useful in the search of new tools to fight against the disease. 
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2. Interaction of M. tuberculosis with the innate immune system 
Tuberculosis is primarily acquired through inhalation of airborne droplets containing the 
viable bacilli which travel to distal regions of the lung where they are recognized by the 
pulmonary innate immune system that plays a key role in the recognition of microbes 
entering via the respiratory route. These early interactions constitute an important link 
between innate immune response and the subsequent activation of adaptive immune 
response that although sufficient to contain the microorganisms is enabling to eliminate 
them. The molecules of bacteria and host involve in these interactions are known as 
pathogen-associated molecular patterns (PAMPs) and pattern recognition receptors (PRR) 
respectively (Salgame, 2005). 
The PRRs include the Toll-like receptors (TLRs) which are type I transmembrane proteins 
characterized by an extracellular domain containing leucine-rich repeats and a cytoplasmic 
tail that contains a conserved region called the Toll/IL-1 receptor (TIR) domain (Medzhitov 
et al., 1997). Ten human and twelve murine TLRs have been characterized, TLR1 to TLR10 in 
humans and TLR1 to TLR9, TLR11, TLR12 and TLR13 in mice, the orthologous of TLR10 
being a pseudogene. Specific interaction of TLRs with microbial ligands triggering 
proinflamatory citokines such as TNF-α, IL-1 and IL-12 generated through the adaptor 
molecule myeloid differentiation primary response protein 88 (MyD88) (Giacomini et al., 
2001; Underhill et al., 1999; Kiemer et al., 2008). Moreover, the in vivo importance of the TLR-
mediated signal in host defense to M. tuberculosis was highlighted in studies using mice 
lacking MyD88, these animals are highly susceptible to airborne infection with M. 
tuberculosis. In contrast, mice lacking individual TLRs are not dramatically susceptible to M. 
tuberculosis infection, suggesting these observations that multiple rather than single TLRs are 
required for the innate defense against mycobacteria. Remarkably, adaptive immunity is not 
impaired in MyD88-deficient mice during the course of M. tuberculosis infection (Fremond et 
al., 2004; Scanga et al., 2004; Hölscher et al., 2008).  
2.1 Interaction of M. tuberculosis with Toll-like receptors 
Studies using gene knockout mice have shown a role for TLR2, TLR4, TLR6, and TLR9 
(Reiling et al., 2002; Sugawara et al., 2003; Bafica et al., 2005) in protective immunity to 
mycobacterial infection. 
At date, the ligands for TLR2 have been identified and it is now known that TLR2 
recognizes M. tuberculosis lipoglycans and lipoproteins, as well as and a member of the 
PE_PGRS family. 
2.1.1 Lipoarabinomanan (LAM) and Lipomannan (LM) 
LAM and LM are integral parts of the mycobacterial cell wall. They are composed of a 
carbohydrate backbone made of a D-mannan core and a D-arabinan domain. Several reports 
have described a TLR2-dependent cell activation by mycobacterial cell wall lipoglycans 
(mannose-capped lipoarabinomannan (ManLAM), phosphatidyl myo-inositol mannosides 
(PIM2 and PIM6)). Typically, Man-LAM from pathogenic mycobacteria have been reported 
to be anti-inflammatory molecules, inhibiting the production of IL-12 and TNF- and 
increasing IL-10 production by dendritic cells or monocytic cell lines, whereas 
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phosphoinositol-substituted LAM from nonpathogenic species are proinflammatory 
molecules stimulating the production of TNF- and IL-12 (Means et al., 1999; Jones et al., 
2001; Gilleron et al., 2003). 
LM, but none of the corresponding LAM, induce macrophage activation dependent on the 
presence of TLR2 and exerted also a potent inhibitory effect on TNF-, IL-12p40, and Nitric 
Oxide (NO) production by Lipopolysaccharide (LPS)-activated macrophages. These results 
provide evidence that mycobacterial LM bear structural motifs susceptible to interact with 
different pattern recognition receptors with pro or anti-inflammatory effects (Quesniaux et 
al., 2004). 
2.1.2 LpqH (Rv3763) or 19 kDa protein 
The 19 kDa cell wall-associated and secreted glycolipoprotein (Garbe et al., 1993), induce 
apoptosis in differentiated THP-1 cells and monocyte-derived macrophages being this effect 
TLR2-mediated. This protein also inhibits IFN--regulated MHC-II expression on alveolar 
macrophages, dependent on TLR2. Although native LpqH is a mycobacterial glycolipoprotein, 
based upon the use of recombinant where the acylation signal had been removed, it was 
concluded that it is the polypeptide component of 19 kDa is responsible for signaling through 
TLR2 and that the lipid moiety is not required (López et al., 2006; Fulton et al., 2004). 
2.1.3 LprG (Rv1441c) or P27 protein 
The LprG is a 27 kDa secreted glycolipoprotein (Gonzalez-Zamorano et al., 2009). It had 
been shown that after prolonged exposure (>16 h) of human macrophages to this protein, a 
marked inhibition of MHC-II antigen processing dependent on TLR2 occur. Short-term 
exposure (<6 h) to LprG stimulated TLR2 dependent TNF- production. Inhibition of MHC-
II antigen processing by mycobacterial lipoproteins may allow M. tuberculosis, within 
infected macrophages, to avoid recognition by CD4 T cells that represent a negative 
feedback mechanism for control of inflammation that may be subverted by M. tuberculosis 
for immune evasion. As observed with LpqH nonacylated LprG retains TLR2 activity 
(Drage et al., 2010; Gehring et al., 2004).  
2.1.4 LprA (Rv1270c) 
The LprA a 24 kDa cell wall-associated lipoprotein with no homologs outside the slow-
growing mycobacteria induced expression of TNF-, IL-10 and IL-12. The protein had 
agonist activity for both human and murine TLR2. LprA also induced dendritic cell 
maturation as shown by increased expression of CD40, CD80, and MHC-II. In macrophages, 
prolonged (24 h) incubation with LprA decreased IFN- induced MHC-II antigen processing 
and presentation, consistent with an observed decrease in MHC-II expression. In contrast 
with LpqH and LprG, only acylated LprA showed the agonist activity (Pecora et al., 2006).  
2.1.5 PstS1 (Rv0934) or 38 kDa antigen 
The 38 kDa a phosphate binding glycoprotein has been considered as an immunodominant 
antigen for its capacity to evoke a prominent cellular and humoral immune responses in 
tuberculosis (Espitia et al., 1989a; Zhu et al., 1997). The protein acting through both TLR2 
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and TLR4, induces the activation of the Extracellular Signal Regulated Kinase (ERK1)/2 and 
p38 Mitogen-activated protein kinase 1(MAPK1) pathways, which in turn play an essential 
role in TNF- and IL-6 expression (Jung et al., 2006). 
2.1.6 PE_PGRS33 (Rv1818c)  
The 45 kDa protein is a member of PE_PGRS family. These sequences were initially described 
by Poulet and Cole in 1995 as GC rich sequences (PGRS, polymorphic GC repetitive sequence) 
in the genome of M. tuberculosis (Poulet & Cole, 1995). They have a conserved Pro–Glu motif 
(PE domain) in their N-terminal, and in C-terminal an alanine and glycine rich domain (PGRS 
domain). Nearly 100 genes belonging to the PE family scattered throughout the M. tuberculosis 
genome (Cole et al., 1998). The PE_PGRS33 is surface exposed protein (Brennan et al., 2001), that 
elicits TNF-release from macrophages in a TLR2 -dependent manner. ASK1 (apoptosis signal-
regulating kinase 1) is activated downstream of TLR2. ASK1 activates the MAPKs p38 and c-Jun 
N-terminal kinases (JNK). PE_PGRS33-induced signaling leads to enhanced expression of TNF- 
and TNF- receptor (TNFR1) genes. Release of TNF- plays the determining role in triggering 
apoptosis in macrophages challenged with PE_PGRS33 (Basu et al., 2007). 
2.2 Interaction of M. tuberculosis with non-Toll-like receptors 
Several recent findings have indicated that PRRs other than TLRs (non-TLRs) evoke innate 
immune responses. Among non-TLRs that interact with M. tuberculosis are the complement 
receptors 3 (CR3). The nucleotide-binding oligomerization domain (NOD)-like receptor 2 
(NOD2) and members of C-type lectins receptors. 
2.2.1 Complement receptor 3 (CR3)  
M. tuberculosis can bind to several types of receptors on the surface of mononuclear 
phagocytes including complement receptors 3 (CD11b/CD18) which is a heterodimer 
belonging to the leukocyte 2-integrin family. This receptor binds complement fragment C3bi 
and also contains a carbohydrate binding site. M. tuberculosis can bind to the complement 
receptors via both complement-dependent and independent pathways (Cywes et al., 1997). 
The presence of human serum containing active complement components was found to 
enhance the binding of M. tuberculosis on the surface of human monocytes and monocyte-
derived macrophages. CR3 was identified as the major component in human serum 
involved in enhancing the adherence and uptake of M. tuberculosis by mononuclear 
phagocytes (Schlesinger et al., 1990). By using affinity blot with C3 complement protein it 
was found that C-terminal region of M. tuberculosis heparin-binding hemagglutinin (HBHA 
(Rv0475) bound human C3. The presence of complement-sufficient serum increased the 
adherence of the HBHA-coated beads to the J774 cells, suggesting these results that the 
protein may enhance the adherence and phagocytosis of M. tuberculosis to mononuclear 
phagocytes through the binding of C3 and interaction with C3 receptors on mononuclear 
phagocytes (Mueller-Ortiz et al., 2001, 2002). 
2.2.2 Nucleotide-binding oligomerization domain (NOD)-like receptor 2 (NOD2) 
NOD2 also known as CARD15, this protein activates innate immunity in response to 
peptidoglycan-derived muramyl dipeptide (MDP). Indeed, defects in NOD2 signaling lead 
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to impaired in vitro mycobacteria recognition by human or murine-derived macrophages 
(Saiga et al., 2011). Studies in macrophages from NOD2-deficient mice indicate that NOD2 
mediates resistance to mycobacterial infection via both innate and adaptive immunity 
(Divangahi et al., 2008). 
2.3 C-type lectin receptors involved in the recognition of mycobacteria 
C-type lectin receptors are a family of proteins of innate immune system that bind 
surfactants and mannose-binding lectin protein (MBL). In addition, there are cell-associated 
C-type lectins, including the mannose receptor (MR), dendritic cell-specific ICAM-3-
grabbing nonintegrin (DC-SIGN), DC-associated C-type lectin-1 (Dectin-1) and macrophage 
inducible C-type lectin (Mincle) (Torreles et al., 2008). Some C-type lectin receptors are 
expressed on the plasma membrane or on the endosomal/phagosomal membrane, whereas 
NOD-like receptors are expressed within the cytoplasm. Indeed, distinct patterns of TLR 
and NOD like receptor-mediated gene expression profiles have been demonstrated in 
infection with intracellular bacteria (Saiga et al., 2011). 
2.3.1 Macrophage Mannose Receptor (MR) 
Macrophages primarily use the MR as well as CR3 for the phagocytosis of M. tuberculosis. 
Interaction of pathogenic M. tuberculosis with the human MR was first demonstrated by 
Schlesinger., 1973, and ManLAM was proposed as the molecule responsible for the specific 
MR-mediated phagocytosis of pathogenic (Schlesinger et al., 1994). It was also demonstrated 
that engagement of the MR by ManLAM during the phagocytic process directs M. 
tuberculosis to its initial phagosomal niche, thereby enhancing survival in human 
macrophages in part by limiting phagosome lysosome fusion, being ManLAM responsible 
for blocks phagosome maturation (Kang et al., 2005). It was also shown that the macrophage 
MR, may interact with mannose residues of mycobacterial lipoglycoprotein LpqH 
promoving phagocytosis of mycobacteria (Diaz-Silvestre et al., 2005). 
2.3.2 Dendritic-cell-specific intercellular adhesion molecule-3-grabbing non-integrin 
(DC-SIGN) 
This Calcium-dependent carbohydrate-binding protein has specificity for mannose-
containing glycoconjugates and fucose-containing Lewis antigens. In recent years, DC-SIGN 
has gained an exponential increase in attention because of its involvement in multiple 
aspects of immune function. Besides being an adhesion molecule, particularly in binding 
intercellular adhesion molecule 2 (ICAM-2) and intercellular adhesion molecule 3 (ICAM-3), 
it is also crucial in recognizing several endogenous and exogenous antigens. Additionally, 
the intracellular domain of DC-SIGN includes molecular motifs, which enable the activation 
of signal transduction pathways (Švajger et al., 2010). Mannosylated moieties of the M. 
tuberculosis cell wall, such as ManLAM or PIMs were previously shown to bind to DC-SIGN 
on immature dendritic cells and macrophage subpopulations. This interaction reportedly 
impaired dendritic cell maturation, modulated cytokine secretion by phagocytes and 
dendritic cells and was postulated to cause suppression of protective immunity to 
tuberculosis (Geijtenbeek et al., 2003). However, experimental M. tuberculosis infections in 
mice transgenic for human DC-SIGN revealed that, instead of favoring immune evasion of 
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mycobacteria, DC-SIGN may promote host protection by limiting tissue pathology. 
Furthermore, infection studies with mycobacterial strains genetically engineered to lack 
ManLAM or PIMs demonstrated that the ManLAM/PIM–DC-SIGN interaction was not 
critical for cytokine secretion in vitro and protective immunity in vivo. The dominant M. 
tuberculosis-derived ligands for DC-SIGN are presently unknown, and a major role of DC-
SIGN in the immune response to M. tuberculosis infection may lie in its capacity to maintain 
a balanced inflammatory state during chronic tuberculosis (Ehlers, 2010). Recent studies 
suggest more varied modes of binding to multiple mycobacterial ligands. Four novel 
ligands of M. bovis BCG that bind to DC-SIGN were identified; chaperone protein DnaK, 60 
kDa chaperonin-1 (Cpn60.1), glyceraldehyde-3 phosphate dehydrogenase (GAPDH) and 
lipoprotein LprG. Of these, only LprG appears to bind DC-SIGN via typical proteinglycan 
interactions (Carroll et al., 2010). Additional ligands, possibly including the mannosylated 
19 kDa (LpqH) and 45 kDa (Apa) glycoproteins had been also proposed as a potential 
targets of DC-SIGN (Pitarque et al., 2005). 
2.3.3 Dendritic cell-associated C-type lectin-1 (Dectin-1) 
This is a fungal pattern recognition receptor that binds to -glucans and triggers cytokine 
production by facilitating interaction with TLR2 or by directly activating spleen tyrosine 
kinase (Syk). Recognition of mycobacteria by Dectin-1 has been shown to induce expression 
of TNF-, IL-6, and IL-12. The significance of these findings is unclear at present because 
mycobacteria are not known to contain -glucans (Yadav & Schorey, 2006; Rothfuchs et al., 
2007). 
2.3.4 Macrophage inducible C-type lectin (Mincle) 
This molecule is expressed in macrophages subjected to several types of stress. Mincle 
possesses carbohydrate-recognition domain (CRD) within the extracellular region. It has 
recently been shown that Mincle recognize the trehalose-6,6-dimycolate (TDM, also called 
cord factor), a mycobacterial cell wall glycolipid that is the most studied 
immunostimulatory component of M. tuberculosis, thereafter modulating macrophage 
activation. TDM activated macrophages to produce inflammatory cytokines and  
NO, which are completely suppressed in Mincle-deficient macrophages (Ishikawa et al., 
2009). 
2.3.5 Pulmonary surfactant protein A and D ( Sp-A and Sp-D) 
C-type Ca2+-dependent lectins are pulmonary collagenous soluble proteins that are secreted 
into the alveoli by resident type II alveolar epithelial cells and distal bronchiolar Clara cells. 
They form a complex structure with lipids and proteins that reduces surface tension of 
alveoli and promotes lung expansion. These proteins bind to pathogens, mediate uptake 
into phagocytes, and modulate effector mechanisms such as oxidant production, lung 
inflammation, and bacterial killing (LeVine et al., 2000). Ferguson and Schlesinger identified 
ManLAM as a potential ligand of human Sp-D (Ferguson & Schlesinger, 2000). It was also 
found that purified human Sp-A exclusively binds to alanine and proline-rich antigenic 
(APA or 45/57 kDa antigen (Rv1860) glycoprotein. This result was supported by direct 
binding of Sp-A to purified APA. Moreover, EDTA addition or deglycosylation of purified 
www.intechopen.com
 
Host–Pathogen Interactions in Tuberculosis 
 
49 
Apa samples completely abolished the interaction, demonstrating that the interaction is 
Calcium and Mannose-dependent, as expected (Ragas et al., 2007).  
2.3.6 Mannose Binding Lectin (MBL) 
This 32 kDa protein provides first-line defense against several microbes, the protein possess 
a collagen-like domain as well as a CRD that binds to high mannose and N-
acetylglucosamine oligosaccharides present on a range of pathogens, including M. 
tuberculosis (Garred et al., 1997). MBL activates the complement pathway in an antibody-
independent manner in conjunction with the MBL-associated serine protease and leads to 
phagocytosis through the complement or collectin receptors (Berrington & Hawn, 2007). 
3. Interaction of M. tuberculosis with extracellular matrix proteins 
Bacterial species gain access to the human body through different tissues and invasion is 
generally mediated by bacterial surface and secreted molecules (Sun, 2006). Bacterial 
colonization, whether benign or pathological, requires the colonizing organism to bind with 
some avidity to the host. Bacteria have evolved a wide range of molecules, known as 
adhesins to enable them to bind to selected host molecules. Most high-affinity bacterial 
adhesins are proteins, and the major targets for them are the host extracellular matrix 
proteins (ECM) which are also present in the cell surface of animal cells (Henderson et al., 
2011). Pathogenic bacteria have evolved mechanisms to exploit molecules present in 
membranes for their own purposes including mediating attachment to target cells through 
the interaction with ECM proteins such as proteoglycans, fibronectin (Fn) and laminin 
among others. 
Tuberculosis commonly affects the lung but, from the initial focus of infection the bacilli can 
spread mainly through the blood, but also via lymphatic to other areas of the lung and other 
organs (Leung, 1999). The dissemination process may allow the bacilli reach regions such as 
central nervous system, genital tract, intestine, skin, bones, digestive system tissue 
associated and integumentary system. The ability to spread seems to be determined more by 
mycobacterial factors since it has been observed that extrapulmonary strains showed a 
greater ability to spread and were more efficient for the invasion (Mischenko et al., 2004; 
Garcia de Viedma et al., 2003, 2005). 
For many years, it was thought that macrophages were the cells primarily involved in the 
interaction of tubercles bacilli with the host. However, it is now known that M. tuberculosis is 
also able to invade non-phagocytic cells such as the respiratory epithelial cells and epithelial 
cells M. Direct adherence and penetration may be important to gain access to the 
hematogenous and lymphatic systems and therefore dissemination (Menozzi et al., 2002; 
Teitelbaum et al., 1999). Bacilli also may interact with pneumocytes causing necrosis and 
destruction of cellular barriers, which could facilitate its passage into the bloodstream and 
allow the invasion. Binding to ECM may be of relevance to the entry of pathogenic 
mycobacteria into nonprofessional phagocytic cells (Bermudez et al., 2002). 
3.1 Mycobacterial fibronectin binding proteins 
Fn is a large and essential multidomain glycoprotein with multiple adhesive properties, 
functioning as a key link between cells and their ECM. Fn is recognized to be the target 
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for a large number of bacterial proteins, which are generally considered to function as 
bacterial adhesins. The ability to bind to Fn has been reported for bacterial pathogens like 
Staphylococcus aureus, Streptococcus pyogenes and Borrelia burgdorferi, and protozoa like 
Trypanosoma cruzi. Fn plays a vital role in a variety of normal physiological processes, its 
targeting appears to be another example of the exploitation of a host cell process in the 
dissemination, establishment and maintenance of infection (Pasula et al., 2002; Henderson 
et al., 2011). The interaction of Fn with mycobacteria seems to be conserved within the 
genus. Fn is required for the anti-tumoral effect of M. bovis BCG on superficial bladder 
tumors. Fn is not exposed on normal bladder epithelia, and adhere of BCG cells only 
occur when uroepithelia is damaged. Blocking of BCG attachment to Fn consequently 
prevents immune responses and inhibits the expression of anti-tumor (Hudson et al., 
1990; Sinn et al, 2008).  
3.1.1 Proteins of antigen 85 complex 
One of the first proteins described as a Fn binding proteins (FnBPs) were the members of the 
antigen 85 complex (Abou-Zeid et al., 1988) which consists of three proteins termed antigen 
85A, 85B and 85C, encoded by three different genes (Rv3804c, Rv1886c and Rv0129c 
respectively). They are mycolic acid transferases present in many mycobacteria species. The 
complex a potent immunogen, is clearly one of the major antigen in the immune response to 
M. tuberculosis infection. For this reason is one of the stronger vaccine candidates (Giri et al., 
2006; Romano et al., 2006). 
The interaction of antigen 85B with Fn involves the binding of multiple regions of this 
protein to the collagen-binding domain of Fn (Peake et al., 1993). Peptide mapping of the 84-
110 sequence defined residues 98-108 as the minimum inhibitory motif with six residues 
(FEWYYQ) to be the most important for Fn interaction. This motif forms a helix at the 
surface of the protein and has no homology to other known prokaryotic and eukaryotic 
FnBP features and appears to be unique to the mycobacteria (Naito et al., 1998). 
3.1.2 Malate synthase G (Rv1837c) 
This cytoplasmic protein is involved in the glyoxylate pathway. The binding site in malate 
synthase G (MS) for Fn, lies in a C-terminal region of the protein that is unique to M. 
tuberculosis. The protein is secreted and is anchored on the cell wall by an undefined 
mechanism. MS expressed in M. smegmatis localizes to the cell wall and enhances the 
adherence of bacteria to lung epithelial A549 cells. Present in the bacterial surface this 
protein is also able to bind to laminin. These studies show that a housekeeping enzyme of 
M. tuberculosis contributes to its armamentarium of virulence promoting factors (Kinhikar et 
al., 2006). 
3.1.3 Alanine and proline-rich antigenic (APA) (Rv1860) or 45/47 kDa antigen 
These 40/45 kDa glycoproteins (Espitia et al., 1989b; Dobos et al., 1996) have a very highly 
conserved alanine and proline-rich 300–350-residue sequence and is apparently unique to 
mycobacteria. Using synthetic peptides the minimal binding sequence to Fn was determined 
to be 12 amino acids, 269–280 and sequence necessary for Fn binding is a motif RWFV (273–
276). Furthermore, the data suggest that mycobacterial Fn-attachment protein (FAP) 
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proteins, all of which share the RWFV binding motif, constitute a family of highly 
homologous proteins that bind Fn in a unique manner (Zhao et al., 1999; Schorey et al., 
1996). 
3.1.4 PE_PGRS proteins 
Although, PE_PGRs are a large family of proteins, the capacity to bind to Fn had been only 
determine in a few members of the family like Wag22 (Rv1759c) antigen (Espitia et al., 1999). 
More recently, we also found that PE_PGRS33 (Rv1818c) and PE_PGRS1 (Rv0109) are also 
bind Fn, being the Fn binding site localized in the PGRS domain, however the motifs 
involved are unknown (unpublished observations). 
3.1.5 Glutamina syntethase A1 (GlnA1) (Rv2220) 
An essential protein of M. tuberculosis that plays a role in nitrogen metabolism. Its enzymatic 
activity detected in culture filtrates of pathogenic but not of nonpathogenic mycobacteria, has 
been associated with virulence. Interestingly, we found that GlnA1 was also able to bind to Fn, 
a feature so far not described in spite of evidence indicating the presence of Fn-binding 
molecules in the range of 57–60 kDa the GlnA1 molecular mass (Xolalpa et al., 2007). 
3.2 Mycobacterial heparin binding protein 
Heparin, a sulfated polysaccharide belonging to the family of glycosaminoglycans, has 
numerous important biological activities, associated with its interaction with diverse 
proteins. Heparin and the structurally related heparan sulfate are complex linear polymers 
comprised of a mixture of chains of different length, having variable sequences. Heparan 
sulfate is ubiquitously distributed on the surfaces of animal cells and in the ECM. It also 
mediates various physiologic and pathophysiologic processes. In M. tuberculosis an heparin-
binding protein has been identified. 
3.2.1 Heparin-binding hemagglutinin (HBHA) (Rv0475) 
In 1996, Menozzi et al. identified a mycobacterial protein of 199 amino acids with a 
molecular weight of 28 kDa that binds heparin (Menozzi et al., 1996). This protein promotes 
the binding of rabbit erythrocytes and mycobacterial aggregation. Antibodies against HBHA 
inhibit haemaglutination, bacterial aggregation and binding the bacteria to epithelial cells. 
HBHA binds to sulfated carbohydrates from a region rich in lysine and proline, thus 
promoting its binding to host tissues (Menozzi et al., 1998). Later, it was demonstrated that 
this protein is involved in extrapulmonary dissemination in a mouse model of tuberculosis, 
bacteria mutated in HBHA decreased spread to the lung, liver and spleen and this ability 
was restored by complementing the mutants with wild-type gene. These results suggest that 
HBHA is essential for the escape of mycobacteria in the lung and the establishment of 
extrapulmonary (Pethe et al., 2001). 
Menozzi et al. showed in 2006 that this protein induces a reorganization of the actin 
filaments in a barrier of endothelial cells, but does not affect the tight junctions. This protein 
mediates the binding and internalization of mycobacteria in human laryngeal epithelial cell 
line (HEp-2) and type II pneumocytes cell line (A549). Apparently lysine rich C-terminal 
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region is mediating these biological effects (Menozzi et al., 2006). In addition to be an 
important adhesin in tuberculosis HBHA is also an important antigen. 
3.3 Mycobacterial laminin binding proteins 
Laminin is a large (900 kDa), highly glycosylated multidomain protein found in all human 
tissues. The laminins are an important and biologically active part of the basal lamina, 
influencing cell differentiation, migration, adhesion as well as phenotype and survival. 
Laminins are trimeric proteins that contain an -chain, a -chain, and a -chain. The trimeric 
proteins intersect to form a cross-like structure that can bind to other cell membrane and 
ECM (Timpl et al., 1979; Aumailley et al., 2005). Adhesion to laminin it is a starting point of 
tissue invasion for many pathogenic bacteria. Mycobacterial protein capable of binds 
laminin had been also identified. 
3.3.1 Histone-Like Protein (HLP) (Rv2986c) or HupB protein 
A cationic surface protein of twenty amino acids was identified as laminin binding protein 
in Mycobacterium leprae (ML-LBP21). This cell wall protein increased the binding of 
mycobacteria to the surface of Schwann cells through its binding to laminin-2  chains. ML-
LBP21 showed 78% of identity with the HupB/HLP protein of M. tuberculosis which is also 
able to bind to laminin of cell surface of murine sarcoma, epithelial cells and human 
pneumocytes (Prabhakar et al., 1998; Shimoji et al., 1999; De Melo et al., 2000). In addition, 
two heparan sulphate binding sites were found in Hlp (Portugal et al., 2008). 
3.3.2 Early Secretory Antigenic Target (ESAT-6) (Rv3875) or EsxA protein 
Comparative studies have identified 16 regions of difference (RD1-16) between the genomes 
of M. tuberculosi and M. bovis BCG, of which one deletion, termed RD1, is absent from all M. 
bovis BCG substrains currently used as vaccines. RD1 includes 15-gene locus (ESX-1), which 
encodes a secretion system type VII that enables the secretion of several proteins including 
ESAT-6 and CFP-10. Both proteins have been considering relevant for cell immune response 
against tuberculosis bacilli. ESAT-6 has recently been demonstrated to cause haemolysis and 
macrophage lysis and also causes cytolysis of type 1 and type 2 pneumocytes. Since both 
types of pneumocytes express membrane laminin, and ESAT-6 exhibits dose-dependent 
binding to purified human laminin, these observations suggest that the specific association 
of ESAT-6 with the bacterial surface is mediated thought laminin (Kinhikar et al., 2010). 
3.3.3 Mammalian Cell Entry operon (MCE) proteins 
Although, the host receptor for MCE proteins is unknown, it is important to mention that 
mce genes encode adhesins and invasins proteins located on the surface of mycobacteria. 
The first adhesion of this operon was by Arruda et al. in 1993; by using a gene library of M. 
tuberculosis they were able to confer to non-pathogenic Escherichia coli the ability to invade 
epithelial HeLa cells (Arruda et al., 1993). Subsequently, it was demonstrated the existence 
of other genes arranged in an additional mce operons (Parker et al., 1995). 
The role of membrane protein MCE-1A in invasion of mycobacteria was demonstrated in 
vitro, this protein induces membrane invagination and entry into HeLa cells. The processes 
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were inhibited with cytochalasin D and nocodazole indicating that rearrangements in 
microtubules and filaments are necessary to membrane invagination MCE-1A-mediate. The 
activity of this protein is given by a domain located in the central region of the protein called 
INV-3 (Lu et al., 2006). By comparing the predicted secondary structure for MCE-1A, MCE-
2A, MCE-3A and MCE-4A proteins was found that there is 70% similarity and contain 
domains alpha/beta. On analysis by predicting the structure of proteins is found that the 
beta domain is probably involved in cell binding (Mitra et al., 2005).  
4. Pathogen interaction with the fibrinolityc system 
The fibrinolytic system is composed by the zymogen plasminogen (Plg), that is activated to 
serine protease plasmin (Plm) by tissue plasminogen activator (tPA) and urokinase-type 
plasminogen activator (uPA). The activity of tPA and uPA is regulated by plasminogen 
activation inhibibors 1 and 2 (PAI-1 and PAI-2), whereas Plm activity is regulated by -2 
antiplasmin and -2 macroglobulin. Plm degrades fibrin deposition in blood cloths and also 
can activate latent matrix metalloproteinases (MMPs) and other protein molecules. During 
infectious diseases, the Plg-Plm system also called fibrinolytic system; suffer alteration in 
their balanced expression, caused mainly by inflammation, besides the binding and 
interaction of some pathogen molecules with components of this system. 
In recent years, several studies have suggested important roles for fibrinolityc system in 
bacterial infections. The microorganims interact with the Plg-Plm system in different ways; 
by immobilizing Plg on their surfaces through Plg receptors (PlgR) an event that conducts to 
activation of Plg by host plasminogen activators (PAS) to generate enzymatically active Plm, 
or by expressing molecules that can activate Plg by themselves. PlgR have been detected in 
virus (Chaipan et al., 2009), fungus (Crowe et al., 2003), parasites (Avilán et al., 2011) and 
bacteria. Among bacteria are Borrelia burgdorferi (Fuchs et al., 1994), Escherichia coli 
(Kukkonen et al., 1998; Lähteenmäki et al., 1993; Parkkinen et al., 1991), Salmonella 
typhimurium (Korhonen et al., 1997; Kukkonen et al, 1998; Lähteenmäki et al., 1995), Neisseria 
meningitidis (Ullberg et al., 1992) and Haemophilus influenzae (Sjostrom et al., 1997) and group 
A, B and C of streptococci (Lähteenmäki et al., 2001b; Coleman & Benach, 1999). In contrast 
to the high number of PlgR described in bacteria, only a few PAs has been identified, the 
plasminogen activator in Yersinia pestis (Pla) (Perry & Fetherston, 1997; Sodeinde et al., 
1992), the staphylokinase (SK) of Staphylococcus aureus (Esmon & Mather, 1998; Lijnen et al., 
1994) and the streptokinase (SAK) of Streptococcus pyogenes (Li et al., 1999; Sun et al., 2004). 
Pla is an aspartic protease that cleaves Plg at the same peptide bond as tPA and uPA. It is 
also an adhesin with affinity for ECM and laminin (Kukkonen et al., 2001; Lähteenmäki et 
al., 2001a, 2001b). SAK and SK are not enzymes themselves, but they form 1:1 complexes 
with Plg, inducing conformational changes in Plg that allows its activation to Plm. SK in 
bacterial virulence has been studied most thoroughly in group A streptococci (GAS), which 
is an invasive pathogen that causes diseases ranging from mild pharyngeal and skin 
infections to potentially fatal disorders, such as toxic shock syndrome. GAS infects only 
humans and is specific for human Plg and the role of SK and Plg in GAS infection was 
confirmed in transgenic mice expressing human Plg (Sun et al, 2004). 
Adherence to ECM and Plg activation on bacteria surface either by host or bacteria owns 
PAs seems to be the mechanisms used for bacteria to colonize and invade the host tissues. 
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Since similar mechanisms are typical for tumor cell migration and invasion (Mignatti & 
Rifkin, 1993) where Plm directly degrades laminin, a major glycoprotein of basement and 
indirectly damages tissue barriers by activating MMPs, the term “bacterial metastasis” is 
now used in analogy to tumor cells metastasis (Plow et al., 1999; Läteenmäki et al., 2000, 
2005). 
It is worth of note that although the list of microorganism that possess PlgR is large, many of 
the identified receptors belong to a group of surface-localized housekeeping enzymes that 
enhance virulence of several, mainly Gram-positive bacterial species; even though the 
mechanism of their secretion into the cell surface is not known (Pancholi & Chhatwal, 2003). 
It is also remarkable that some of PlgR also bound to ECM proteins. Together these 
observations suggest that Plm-mediated fibrin degradation could be a mechanism that 
advances the spread of invasive bacteria within the mammalian host (Sun et al., 2004).  
4.1 Mycobacteria interactions with human fibrinolytic system 
In the course of mycobacterial infections the fibrinolytic activity demonstrated a remarkable 
increased, the first publication in this field was issued by Smokovitis and colleagues in 1976, 
showed that intradermicaly inoculation of M. bovis BCG in rabbits triggered lesions in the 
dermis, with increment of focal fibrinolytic activity caused by a PA detected in lesions fluids 
and by histology and fibrin slide technique; 2 weeks later, when hypersensitivity to the M. 
bovis BCG vaccine became pronounced and caseous centers developed, fibrinolytic activity 
was particularly high (Smokovitis et al., 1976). An intact coagulation mechanism, including 
tissue factor generation, appears to be important for the development of skin test induration 
in humans skin since anticoagulation with warfarin decreased skin test induration and 
tissue factor generation, but lymphocyte transformation remained unchanged (Edwards & 
Rickles, 1978). 
Macrophages obtained from infected mouse with M. bovis BCG and challenged in culture 
with protein-purified derivative (PPD), had increased plasminogen activator activity that 
was dependent of presence of T cells, macrophages obtained from infected animals without 
boosting showed less fibrinolytic activity that those stimulated with PPD and the 
stimulation was abolished by depletion of T cells (Gordon & Cohn, 1978).  
Together these observations indicate that the fibrinolytic system could play an integral role 
in the tuberculosis inflammatory response. The participation of Plg-Plm system in 
inflamation has been documented during the last decade. It has been demonstrated that, 
TNF- induced the expression of PAI-1 and uPA in adipocytes and in human pulmonary 
artery cells respectively (Pandey et al., 2005; Wu & Aird, 2005). PAI-2 transcription is also 
upregulated under the influence of TNF- in fribrosarcoma cells (Medcalf et al., 1988). 
Transcription of urokinase receptor (uPAR), protein located in the membrane of numerous 
cell types, is influenced by TGF- (Lund et al., 1991). tPA transcription is downregulated by 
TNF- in human umbilical vein endothelial cells (Schleef et al., 1988), whereas in fibroblasts 
from human pulp and gingival fibrolasts TNF- and IL-1 induce a significant increase of 
tPA (Chang et al., 2003). 
In pleural effusions of tuberculosis patients levels of TNF- were higher than in complicated 
parapneumonic and cancer patients, whereas tPA concentration was lower Plg and PAI-1 
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levels were higher in tuberculosis patients than the other groups. (Aleman et al., 2003). Lu 
and collaborators, compared the concentration of components of fibrinolytic system in 
pleural and ascytic fluid from tuberculosis, cancer and liver cirrhosis patients, the results 
showed higher levels of uPA and uPAR from tuberculosis and cancer patients with respect 
to cirrhosis patients, whereas tPA level was higher in cancer and cirrhosis patients than 
tuberculosis patients. PAI-1, Plg and Plm levels in tuberculosis patients where statistically 
higher than those levels in cirrhosis and cancer patients (Lu et al., 2007). 
Serum level of soluble uPAR (suPAR) in tuberculosis patients was analyzed in a community 
from Guinea Bissau, the results showed an elevated level of suPAR in active tuberculosis; 
decreasing levels of suPAR where associated with treatment, whereas lower levels of suPAR 
where related with survival (Eugen-Olsen et al., 2002). 
The protease activity of Plm plays an important role in the turnover of ECM in a mice model 
of Mycobacterium avium infection, whereas early dissemination to organs was observed in 
Plm and tPA deficient mice. The authors also demonstrated that fibrin deposition and Fn 
increased in Plg deficient mice during the infection in comparison with wild type mice (Sato 
et al., 2003). 
The first evidence of the presence of PlgR and PAs in M. tuberculosis was reported by 
Monroy and collaborators; the lysine-dependent binding of Plg to mycobacteria was 
demonstrated by FACScan analysis and affinity blotting assays. The specificity of binding 
and the participation of lysine residues in mycobacterial protein-Plg interaction were tested 
in the presence of 0.1, 1, and 2 M -aminocaproic acid (EACA), a lysine analog. Plg binding 
proteins of 30, 60, and 66 kDa detected in bacteria protein extracts was abolished by this 
lysine analog. Furthermore, both soluble protein and total protein extracts could activate Plg 
only in presence of fibrin matrices, suggesting these results, that Plg activation by M. 
tuberculosis requires attachment of Plg to a target molecule. Moreover, addition of -2 
antiplasmin did not significantly decrease activation of Plg by mycobacterial extracts, 
showing that pathogen-associated Plm activity is not blocked efficiently by host serpins 
(Monroy et al., 2000). 
Besides, a recently study revealed the identity of several Plg-binding proteins present in M. 
tuberculosis and that Plg bound to mycobacterial receptors is converted into Plm by tPA, the 
mammalian Plg activator. By proteomic analysis together with ligand blotting assays the 
identity of several Plg-binding spots in the mycobacteria soluble extracts and culture filtrate 
proteins was determined. In ligand blotting assay in polyvinylidene difluouride (PVDF) 
membrane with mycobacterial proteins 2D-SDS-PAGE-resolved reactive spots bound to Plg 
were detected using an anti-Plg antibody, then by N-terminal sequencing and/or mass 
spectrometry (MS) fifteen different proteins were identified from reactive spots, identified 
proteins correspond to DnaK (Rv0350), GroES (Rv3418c), GlnA1 (Rv2220), antigen 85 
complex (Rv3804c, Rv1886c and Rv0129c), Mpt51 (Rv3803c), Mpt64 (Rv1980c), PrcB 
(Rv2110c), MetK (Rv1392), SahH (Rv3248c), Lpd (Rv0462), Icl (Rv0467), Fba (Rv0363c), and 
EF-Tu (Rv0685). Interaction of Plg with these proteins was inhibited by the lysine analogue 
EACA, indicating that the binding was mediated by lysine residues. Among of identified M. 
tuberculosis PlgRs; only DnaK, PrcB, GroES, and EF-Tu have the C-terminal lysine. 
In same work, binding of Plg to DnaK, GlnA1, and antigen 85B was confirmed with 
recombinant proteins by ELISA and ligand blotting assays. These results confirmed findings  
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Mycobacterial 
protein targets 
Host receptors Binding sites References 
LpqH TLR2 Unknown López et al., 2006 
MR Ch Diaz-Silvestre et al., 2006 
DC-SIGN? Ch? Pitarque et al., 2006 
LprG TLR2 Ch Drage et al., 2010 
DC-SIGN Ch Carroll et al., 2010 
LprA TLR2 Unknown Pecora et al., 2004 
APA Sp-A Ch Ragas et al, 2007 
Fn 273RWFV276 Schorey et al.,1996 
DC-SING? Ch? Pitarque et al., 2006 
Hlp Hs Gly46 to Ala60, Thr31 to 
Phe50, C-terminus, Lys 
rich residues  
Portugal et al., 2008  
Shimoji et al., 1999 
Lm C-terminus, Lys rich 
residues  
Soares de Lima et al., 2005 
HBHA 
 
Hs 
 
C-terminus, Lys rich 
domine  
Menozzi et al., 1996 
Pethe et al., 2000 
MS Fn 40 aa C-terminal region Kinhikar et al., 2006 
Lm Unknown Kinhikar et al., 2006 
ESAT-6 Lm Unknown Kinhikar et al., 2010 
PE_PGRS33 TLR2 Unknown Basu et al., 2007 
Fn PGRS domain Unpublished work 
Wag22 Fn PGRS domain Espitia et al., 1999 
PE_PGRS1 Fn PGRS domain Unpublished work 
DnaK DC-SING Unknown Carroll et al., 2010 
Plg Unknown Lys residue Xolalpa et al.,2007 
GlnA1 Fn Unknown Xolalpa et al., 2007 
Plg Unknown Lys residue Xolalpa et al., 2007 
SahH Plg Unknown Lys residue Xolalpa et al., 2007 
Lpd Plg Unknown Lys residue Xolalpa et al., 2007 
Icl Plg Unknown Lys residue Xolalpa et al., 2007 
EF-Tu Plg Unknown Lys residue Xolalpa et al., 2007 
MetK Plg Unknown Lys residue Xolalpa et al., 2007 
Fba Plg Unknown Lys residue Xolalpa et al., 2007 
Antigen 85 
complex  
Fn 98FEWYYQ103 Naito et al., 1998 
Plg Unknown Lys residue Xolalpa et al., 2007 
Mpt51 Fn Unknown Naito et al., 1998; 
Plg Unknown Lys residue Xolalpa et al., 2007 
PrcB Plg Unknown Lys residue Xolalpa et al., 2007 
Mpt64 Plg Unknown Lys residue Xolalpa et al., 2007 
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Mycobacterial 
protein targets 
Host receptors Binding sites References 
GroES Plg Unknown Lys residue Xolalpa et al., 2007 
Cnp60.1  DC-SIGN Unknown Carroll et al., 2010 
GAPDH DC-SIGN Unknown Carroll et al., 2010 
Abreviations:  
Ch Carbohydrates 
Hs Heparan sulphate 
Lm Laminin 
Plg Plasminogen 
MR Mannose Receptor 
Table 1. Host-Mycobacteria proteins involved in interactions. 
with native proteins reported before, that the interaction involved lysine residues. In 
addition Plg bound to recombinant mycobacterial proteins was activated to Plm tPA 
activator (Xolalpa et al., 2007). 
Until now, our results show that M. tuberculosis possesses Plg binding and activating 
molecules present in the soluble protein extracts; based in these evidences works are in 
progress to identify potential PA in mycobacteria. Considering that interaction with the Plg 
system promotes damage of extracellular matrices as well as bacterial spread and organ 
invasion during infection, this suggests a common mechanism in migration of eukaryotic 
and prokaryotic cells that could be used by M. tuberculosis in disease process. M. tuberculosis 
possesses several Plg receptors suggesting that bound Plg to bacteria surface can be 
activated to Plg, endowing bacteria with the ability to degrade ECM and basal membranes 
proteins contributing to tissue injury in tuberculosis. 
5. Influence of genetic variations in host-mycobacteria relationship 
Human tuberculosis results from the interactions between host and bacteria, the degree to 
which genetic variations of both human and mycobacteria influence this relationship has 
become elucidated. 
5.1 Mycobacterial genetic polymorphisms 
Massively DNA sequencing and comparative genomic, together with in vitro and in vivo 
models of M. tuberculosis infection are contributing to define how different clinical 
genotypes of M. tuberculosis affect the innate immune response. There is now evidence that 
strain variation can lead to variable virulence phenotypes and can evoke or suppress host 
immune response (López et al., 2003). 
Recently direct role for strain-variation-associated virulence in suppressing host immune 
response and inducing hyperlethality in mice documented in a subset of clinical isolates 
belonging to the W-Beijing family where the presence of a polyketide synthase-derived 
phenolic glycolipid endowed the strains with hypervirulent phenotype (Reed et al., 2004). A 
recent report also showed how the cyclopropane modification of trehalose dimycolate was 
critical to induce a pro-inflammatory response during the first week of infection in mice 
(Rao et al., 2005). 
www.intechopen.com
 
Understanding Tuberculosis – Analyzing the Origin of Mycobacterium Tuberculosis Pathogenicity 
 
58
On the other wise, genetic polymorphism in M. tuberculosis genome is given by the 
presence of insertion sequence 6110 (IS6110). About 23 copies of this sequence are 
distributed along the genome. Molecular tipification based on number and localization of 
the IS6110 in M. tuberculosis clinical isolates have been used for several molecular 
epidemiology studies. 
However, the sequence can be inserted in promoter region of regulatory genes, modifying 
the expression the genes they regulate, an example is the presence of IS6110 in the promoter 
region of phoP of M. bovis strain B, a multidrug resistant and hypervirulent strain that was 
responsible for a nosocomial outbreak of tuberculosis in Spain (Soto et al., 2004). Many 
copies of IS6110 has been found in or near of pe/ppe genes of M. tuberculosis strain 210, 
responsible of several cases of tuberculosis in Los Angeles, California USA suggest the 
possibility that the insertions could be mediating recombination of these sequences that 
result in changes that endowed the bacteria with high capacity for transmission and/or 
replication (Barnes et al., 1997; Beggs et al., 2000). 
PE/PPE family also showed important variation in their coded sequences. Analysis of 
mutations in PPE38 gene of M. tuberculosis clinical isolates representing all major 
evolutionary lineages, show hypervariability of the PPE38 region consequence of the 
combination of a high frequency of IS6110 insertion events, IS6110-associated 
recombination/deletion events, homologous recombination and gene conversion events 
(McEvoy et al., 2009). 
It is known that one of the most important sources of genetic variability in M. tuberculosis 
complex is given by PE/PPE gene family (Cole et al., 1998; Fleischmann et al., 2002). 
Sequence of pe_pgrs33 gene from 123 M. tuberculosis clinical isolates showed variations 
relative to PE_PGRS33 sequence from H37Rv in 84 (68.3%) of the 123 isolates. Sequence 
variations included insertions, deletions and both as well as single nucleotide 
polymorphisms (SNPs). Variations were more frequently found in the C-terminal PGRS 
domain of PE_PGRS protein and affecting one or more of the glycine-alanine repeats. These 
variations could potentially account for some of the differences in their ability to evade the 
host immune system, and this idea contribute to support the role of the PE_PGRS family in 
antigenic variation (Talarico et al., 2005). 
Furthermore, the study of variations in PE_PGRS33 gene from 649 M. tuberculosis clinical 
isolates showed a possible association of major changes (large insertions/deletions or 
frameshift mutations) in the PE_PGRS33 protein with clustering of tuberculosis cases and 
the absence of cavitations in the lungs, in contrast with patients infected with M. 
tuberculosis isolates having any or minimal changes in the protein (Talarico et al., 2007). 
Basu et al., 2007 also observed that deletions within the PGRS domain attenuate the 
induction of TNF--mediated by PE_PGRS33 through its TLR2. Also in this work was 
observed that the induction of TNF- was specific of PE_PGRS33 and not a common 
feature of the PE_PGRS family, since PE_PGRS48 and PE_PGRS62 did not induced 
production of TNF- at the same level of the PE_PGRS33. These results provide evidences 
that variations in the polymorphic repeats of the PGRS domain modulate the innate 
immune response (Basu et al., 2007). 
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It has been observed that the PE_PGRS genes are differentially expressed in different strains 
of M. tuberculosis during growth in vitro (Flores et al., 2003; Dheenadhayalan et al., 2006) and 
in vivo (Delogu et al., 2006). Interestingly, expression of many of these proteins seems to be 
widely regulated by several conditions (Voskuil et al., 2004; Vallecillo & Espitia, 2010). In 
addition to that, the extreme polymorphism found among the clinical isolates, suggests that 
they could be a major source of antigenic variation in M. tuberculosis (Talarico et al., 2005; 
Santillan et al., 2006). PE_PGRS16 and PE_PGRS26, genes are inversely regulated during 
persistent of M. tuberculosis infection, suggesting that differential expression of these two 
PE_PGRS genes may have a role in latency. The variations in these sequences were also 
studied in 200 strains, 102 (51%) and 100 (50%) showed variations within the PE_PGRS16 
gene and the PE_PGRS26 gene, respectively. Variations consist in insertions and deletions, 
frameshifts, and SNPs. Frameshifts are predominant in PE_PGRS16 gene and in-frame 
deletions in PE_PGRS26 gene. The observed sequence variations could impact the function 
of these protein and could be asociated with different clinical manifestations of tuberculosis, 
but remains to be understood the specific role that these genes play in M. tuberculosis-host 
interaction (Talarico, et al., 2008). 
Sequence analysis of the coded sequence of PPE18 a vaccine candidate in 225 clinical isolated 
of M. tuberculosis showed an important variability that must be considered when potential 
vaccine candidates are selected and evaluated. Evaluation of genetic variability could provide 
important information regarding the ability of the immune response induced by a vaccine 
candidate to recognize different field strains of M. tuberculosis (Hebert et al., 2007). 
Differential gene expression also can contribute to modify the host-pathogen interactions. It 
has been demonstrated that HBHA, the heparin binding protein is differentially expressed 
during the infection with M. tuberculosis, showing a higher expression early infection when 
the bacteria spread from the primary site of infection. In addition, it was also found that 
hbha gene is up regulated in epithelial cells but not in macrophages (Delogu et al., 2006). 
Mutation in Rv0444 gene that codified for the anti-sigma factor K increased the expression of 
MB83 antigen in M. bovis BCG and M. bovis clinical isolates compare with the very low 
expression of this protein in M. tuberculosis (Charlet et al., 2005; Saïd-Salim et al., 2006). 
In a recent work, genome sequences of 21 phylogeographically diverse strains of M. 
tuberculosis complex (16 M. tuberculosis and 4 M. africanum strains representative of the six 
human M. tuberculosis lineages, and one strain of M. canettii) were carried out. The presence 
of 491 human T cell epitopes experimentally determined was evaluated from the genome 
database. The result of the analysis showed that known human T cell epitopes are highly 
conserved suggesting these observations that the hyperconservation of T cell epitopes in M. 
tuberculosis is consequence of a strong selection pressure, perhaps because the immune 
response they elicit in humans, is essential for the survival of an infected individual, and 
might be partially beneficial to the pathogen. One potential mechanism by which the 
mycobacterium could benefit from human T cell recognition is that human T cell responses 
are essential for M. tuberculosis to establish latent infection and one effective transmission to 
new susceptible host (Comas et al., 2010). One important limitation of this study was the 
exclusion of PE/PPE genes, because as it has been commented that the sequence variations 
into some of these genes contributed in significant form to the dynamical parasite-host 
relation. 
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According to the observations of Comas et al. sequence analysis of genes encoding a major 
M. tuberculosis antigens ESAT-6, TB10.4, and antigen 85B from 88 clinical isolates of M. 
tuberculosis revealed no variability in the genes esxA and esxH in all isolates. In the case of 
fbpB (antigen 85B) only one synonymous SNP located at position 714 bp of the gene 
sequence, among 39 (44.3%) of the 88 strains sequenced (Davila et al., 2010). 
5.2 Host genetic variability 
The severity of tuberculosis disease is controlled not only by genetics variations at the level 
of the bacteria but also by host disparities. The presence of SNP (T597C) in TLR2 among 2 
groups of Vietnamese adults with pulmonary or meningeal tuberculosis suggests a strong 
association of TLR2 variation with meningeal tuberculosis. The authors hypothesize that 
polymorphisms in genes of the innate immune response may influence the host response 
resulting in increased susceptibility to disease causing by some bacterial lineages but not 
others (Caws et al., 2008).  
Crohn’s disease itself resembles a chronic intestinal granulomatous infection seen in animals 
called Johne’s disease, which appears to be caused by Mycobacterium avium spp. 
paratuberculosis trigger (Berrington & Hawn, 2007) a controversy exists as to whether 
Crohn’s disease has an environmental or infectious trigger. Frameshift mutations in the  
N-terminal leucine-rich region of NOD2 have been associated with Crohn’s disease in 
adults. More recently, NOD2 variants were found to be associated with susceptibility to 
tuberculosis in an African American population. In light of these findings, the importance of 
NOD2-mediated immunity during a chronic mycobacterial infection requires further study 
(Austin et al., 2008). 
In a study from Mexico, several variants of Sp-A and Sp-D were associated with 
susceptibility to tuberculosis (Floros et al., 2000). These results have not been verified in an 
independent cohort, and the functional significance of the variants has not been reported. 
The continued identification of M. tuberculosis genes or host-encoded will ultimately 
enhance our knowledge of the complex and highly dynamic interaction between the 
pathogen and host (Zahrt et al., 2003). 
6. Adhesins as therapeutic targets 
The emergence of M. tuberculosis Multidrug-resistant strains is now a major public health 
problem all over the world. In this context, it is highly critical to develop a new strategy for 
the treatment of infected patients that supplements the conventional antimycobacterial 
chemotherapeutic drugs. More precise understanding of the host-bacteria interactions will 
pave the way for the development of an effective drug. In this way, targeting bacterial 
colonization through blockade of selective adhesins could be therapeutically useful (Ofek et 
al., 2003; Klemm et al., 2010). There are a number of examples where inactivation of FnBP 
genes or antibodies to FnBPs has resulted in decreased bacterial colonization/virulence 
(Rennermalm et al., 2001; Rivas et al., 2004). Clinically, most work has been carried out on 
the humanized monoclonal antibody tefibazumab, which selectively binds S. aureus ClfA 
(Hetherington et al., 2006). In tuberculosis, patient sera containing anti-HBHA antibodies 
neutralize the entry of M. tuberculosis to epithelial cells, suggest that antibody to HBHA may 
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play a role in protection against mycobacterial extrapulmonary dissemination (Shin et al., 
2006). 
Some important advances of the interaction of mycobacteria and host has been elucidated 
but there is more questions to answer. M. tuberculosis as has been shown in this chapter, 
posseses multiple and diverse molecules that targeting innate immune system, ECM and 
fibrinolytic system. The study of the molecular interactions to define, binding motifs, and 
specificity of these interactions is crucial in the search of new molecular targets. Bacteria 
receptors that result in colonization and invasion are likely to be targeted. 
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